Search

everythinglearnresearchcommunity

for

Search:↓

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

JAK inhibitors offer new hope for treating severe alopecia areata.

Adult women with acne in Iraq often have more severe symptoms and hormone-related issues than younger girls with acne.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Ozone and procaine boost the release of healing factors in platelet-rich plasma.

Herbal remedies can cause adverse effects and need more safety research.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

More research is needed to understand hair and scalp disorders in people with skin of color.